Psychedelic Business Spotlight – April 8
This week in psychedelic business news: Field Trip Health secures a patent; Core One Labs seeks more retail investors; a new CEO takes over GABA Therapeutics.
core one labs
-
-
Another Psychedelics Company Is Crashing
Core One Labs appears to be following in footsteps of Mind Cure, but that doesn’t mean the entire psychedelics industry is in trouble.
-
Psychedelic Business Spotlight- March 11
This week in psychedelic business news: Small Pharma prepares big DMT studies; Health Canada approves a psilocybin PTSD study.
-
Psychedelic Business Spotlight – February 25
This week in psychedelic business news: Core One cheapens psilocybin production; Field Trip eyes Oregon; Small Pharma advances DMT.
-
Psychedelic Business Spotlight – February 11
This week in psychedelic business news: Cybin scores another patent; another huge psychedelics conference heads to Miami; Core One Labs widens pipeline with another drug.
-
Psychedelic Business Spotlight – December 31
This week in psychedelic business news: Mindset Pharma files another patent for compounds with “perfect microdosing drug profile,” and Core One Labs is preparing to capitalize on functional mushroom market.
-
Psychedelic Business Spotlight: August 13, 2021
This week in psychedelic business news: Psychedelics in development to treat eye diseases and stroke; companies gear up for new clinical trials investigating psychedelics for general anxiety, chronic pain, and eating disorders.
-
Third Psychedelic Stock ETF Coming Soon, Core One Labs Prepares to List on NASDAQ
Advisorshares Plant Medicine ETF will be listed on the NYSE Arca under the symbol PSIL.
